SPAC1002.01 Antibody

What is SPAC1002.01 and what is its significance in fission yeast research?

SPAC1002.01 is a protein expressed in Schizosaccharomyces pombe (fission yeast) that has become an important research target for understanding fundamental cellular processes in this model organism. While specific detailed information about this protein's function is limited in the current literature, it appears in comprehensive research focusing on S. pombe proteomics. The gene is cataloged with a systematic name (SPAC1002.01) following standard S. pombe nomenclature, and antibodies against this protein are used primarily for research applications in this organism . The protein has been analyzed alongside other S. pombe proteins in studies investigating protein localization and function, although it does not appear to be among the well-characterized nuclear pore complex (NPC) components detailed in some fission yeast studies .

What are the basic properties of antibodies against SPAC1002.01?

The commercially available SPAC1002.01 antibody is a polyclonal antibody raised in rabbits against a recombinant version of the target protein from Schizosaccharomyces pombe strain 972/ATCC 24843 . The antibody is produced through antigen affinity purification, supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . Like other research antibodies, it undergoes testing for specific applications including ELISA and Western blot to ensure its ability to specifically recognize the target antigen . For experimental validation, researchers should note that the antibody's optimal working conditions, including dilution ratios for different applications, may need to be empirically determined for each specific experimental setup.

What experimental applications is the SPAC1002.01 antibody validated for?

According to product specifications, the SPAC1002.01 antibody has been tested and validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . These techniques represent fundamental approaches for protein detection and quantification in molecular biology research. The antibody's validation for these applications suggests it has demonstrated sufficient specificity and sensitivity to detect the target protein in these formats. Researchers should note that while these are the manufacturer-validated applications, optimization may still be required for specific experimental conditions, and additional applications beyond these (such as immunofluorescence or immunoprecipitation) would require careful validation by the researcher prior to generating publishable data.

What is the species reactivity profile of this antibody?

The SPAC1002.01 antibody has been specifically developed for recognizing the target protein in Schizosaccharomyces pombe (strain 972/ATCC 24843) . This narrow species reactivity profile reflects its development as a research tool for investigators working specifically with this model organism. Cross-reactivity with orthologous proteins in other yeast species or more distant eukaryotes has not been established in the available literature. Researchers working with other model organisms, even closely related yeast species, should not assume cross-reactivity and would need to empirically test the antibody's reactivity with their specific organism of interest before utilizing it in experiments.

What are the optimal Western blot protocols when using SPAC1002.01 antibody?

For Western blot analysis using the SPAC1002.01 antibody, researchers should follow these methodological steps for optimal results:

• Sample Preparation: Extract total protein from S. pombe cells using a compatible lysis buffer (typically containing protease inhibitors to prevent protein degradation).

• Protein Separation: Separate proteins by SDS-PAGE using an appropriate percentage gel based on the expected molecular weight of SPAC1002.01.

• Transfer: Transfer proteins to a PVDF or nitrocellulose membrane using standard transfer conditions.

• Blocking: Block the membrane with 5% non-fat dry milk or bovine serum albumin (BSA) in TBST for 1 hour at room temperature.

• Primary Antibody Incubation: Incubate the membrane with SPAC1002.01 antibody diluted in blocking solution. The optimal dilution should be determined empirically, but typical starting dilutions for polyclonal antibodies range from 1:500 to 1:2000.

• Washing: Wash the membrane 3-5 times with TBST to remove unbound antibody.

• Secondary Antibody: Incubate with an appropriate anti-rabbit HRP-conjugated secondary antibody.

• Detection: Visualize using chemiluminescent detection reagents and an imaging system.

Researchers should include positive and negative controls to validate specificity, and may need to optimize antibody concentration, incubation time, and washing conditions for their specific experimental setup .

How should SPAC1002.01 antibody be stored and handled to maintain activity?

For optimal maintenance of SPAC1002.01 antibody activity, adhere to these evidence-based storage and handling guidelines:

• Storage Temperature: Upon receipt, store the antibody at -20°C or -80°C as recommended by the manufacturer .

• Avoid Freeze-Thaw Cycles: Repeated freeze-thaw cycles can significantly degrade antibody performance. Aliquot the antibody into smaller volumes upon first thaw to minimize future freeze-thaw cycles .

• Working Dilutions: Prepare working dilutions shortly before use and keep on ice while working. Do not store diluted antibody for extended periods.

• Buffer Conditions: The antibody is provided in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 . This formulation helps maintain stability during freeze-thaw cycles and storage.

• Contamination Prevention: Use sterile technique when handling the antibody to prevent microbial contamination.

• Shipping Conditions: If transporting between laboratories, maintain cold chain using dry ice or similar cooling methods.

Following these protocols will help ensure the antibody maintains optimal activity for the duration of your research projects, providing more consistent and reliable experimental results.

What approaches should be used for optimizing ELISA protocols with SPAC1002.01 antibody?

When optimizing ELISA protocols with SPAC1002.01 antibody, researchers should systematically address these key methodological parameters:

• Coating Concentration: Determine the optimal antigen coating concentration through a titration experiment, typically ranging from 1-10 μg/ml of recombinant SPAC1002.01 protein.

• Blocking Agent Selection: Test different blocking agents (BSA, non-fat milk, commercial blocking buffers) to identify which provides the best signal-to-noise ratio with minimal background.

• Antibody Dilution Series: Perform a dilution series of the SPAC1002.01 antibody (e.g., 1:500, 1:1000, 1:2000, 1:5000) to determine the concentration that provides optimal specific signal while minimizing background.

• Incubation Parameters: Optimize both temperature (4°C, room temperature, 37°C) and duration (1 hour to overnight) for antibody incubation steps.

• Washing Stringency: Adjust wash buffer composition (PBS-T or TBS-T) and washing frequency to effectively remove unbound antibody without disrupting specific binding.

• Detection System Optimization: If using an HRP-conjugated secondary antibody, test different substrate systems (TMB, ABTS, etc.) for optimal signal development.

• Positive and Negative Controls: Always include appropriate controls, including a positive control sample known to contain SPAC1002.01 and negative controls without primary antibody or with unrelated primary antibody.

Record all optimization parameters systematically to identify the conditions yielding the highest sensitivity and specificity for your specific application .

What sample preparation methods are recommended for maximum detection of SPAC1002.01?

For optimal detection of SPAC1002.01 in S. pombe samples, implement these methodologically sound preparation techniques:

• Cell Lysis Optimization:

  • For total protein extraction, use glass bead lysis in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 10% glycerol, and 1% NP-40

  • Include protease inhibitor cocktail to prevent degradation of SPAC1002.01

  • Consider phosphatase inhibitors if investigating phosphorylation states

• Subcellular Fractionation: If focusing on nuclear proteins (which may be relevant based on the analysis of other S. pombe proteins ), implement nuclear isolation protocols specific for yeast cells.

• Protein Concentration Determination: Use Bradford or BCA assay to standardize loading amounts across samples.

• Sample Denaturation: Heat samples at 95°C for 5 minutes in Laemmli buffer with β-mercaptoethanol for reducing conditions.

• Protein Precipitation: For dilute samples, consider TCA precipitation to concentrate proteins before analysis.

• Timing Considerations: Process samples quickly and maintain cold temperatures throughout to minimize protein degradation.

• Growth Conditions: Culture S. pombe under standardized conditions, as protein expression may vary with growth phase or environmental stress.

These methodological considerations should enhance detection sensitivity while maintaining the native epitopes recognized by the SPAC1002.01 antibody .

How can SPAC1002.01 antibody be used in the context of chromatin research?

For applying SPAC1002.01 antibody in chromatin research contexts, researchers should consider these methodological approaches:

• Chromatin Immunoprecipitation (ChIP) Adaptation: While not explicitly validated for ChIP, the SPAC1002.01 antibody might be adapted for this application following established ChIP protocols for S. pombe. This would require:

  • Crosslinking optimization (typically 1% formaldehyde for 10-15 minutes)

  • Sonication parameters adjusted for S. pombe cells

  • Thorough validation using known targets or negative controls

  • Quantitative PCR with primers for regions of interest

• Co-immunoprecipitation for Protein Interactions: To identify chromatin-associated protein interactions with SPAC1002.01:

  • Use less stringent lysis conditions to preserve protein-protein interactions

  • Implement two-step immunoprecipitation approaches for higher specificity

  • Consider reversible crosslinking methods to capture transient interactions

  • Follow with mass spectrometry analysis to identify interaction partners

• Integration with Histone Modification Analysis: Based on data suggesting connections between various proteins and histone modifications in S. pombe (such as H4 K20 trimethylation and H4 K16 acetylation mentioned in relation to other proteins ), researchers might:

  • Perform sequential ChIP with SPAC1002.01 antibody followed by histone modification-specific antibodies

  • Analyze co-localization patterns at specific genomic regions

  • Compare wild-type versus deletion strains to assess functional relationships

• Genomic Distribution Analysis: Combine ChIP with high-throughput sequencing (ChIP-seq) to map SPAC1002.01 distribution genome-wide, with particular attention to subtelomeric regions which have shown regulation by various chromatin-associated factors in S. pombe .

These methodologies would need careful optimization and validation, as the application of this antibody in chromatin contexts represents an advanced research application beyond standard validated uses .

What approaches can be used to validate the specificity of SPAC1002.01 antibody?

To rigorously validate the specificity of SPAC1002.01 antibody, implement these comprehensive methodological approaches:

• Genetic Validation:

  • Generate SPAC1002.01 deletion strains in S. pombe

  • Perform Western blot comparing wild-type and deletion strains

  • Absence of signal in deletion strain would confirm specificity

  • Consider complementation with tagged SPAC1002.01 as additional control

• Peptide Competition Assay:

  • Pre-incubate antibody with excess purified recombinant SPAC1002.01 protein

  • Compare results from blocked antibody versus non-blocked antibody

  • Specific signals should be significantly reduced or eliminated

• Overexpression Analysis:

  • Create S. pombe strains overexpressing SPAC1002.01

  • Signal intensity should increase proportionally with expression level

  • Consider using inducible promoters for controlled expression

• Mass Spectrometry Validation:

  • Immunoprecipitate using SPAC1002.01 antibody

  • Analyze precipitated proteins by mass spectrometry

  • Confirm presence of SPAC1002.01 in the immunoprecipitated material

• Cross-Reactivity Assessment:

  • Test antibody against recombinant proteins with similar sequences

  • Evaluate potential cross-reactivity with homologous proteins

• Epitope Mapping:

  • Identify specific epitope(s) recognized by antibody

  • Assess conservation of epitope(s) across potential cross-reactive proteins

How might SPAC1002.01 relate to nuclear pore complex components in fission yeast?

While SPAC1002.01 is not directly identified as a nuclear pore complex (NPC) component in the provided research data, exploring potential relationships requires sophisticated methodological approaches:

• Comparative Localization Analysis:

  • Perform co-immunofluorescence using SPAC1002.01 antibody and established NPC markers (such as spNup132, spNup107, or spNsp1 )

  • Quantify co-localization coefficients to determine spatial relationship

  • Use super-resolution microscopy for precise spatial mapping

• Protein Interaction Network Analysis:

  • Conduct immunoprecipitation with SPAC1002.01 antibody followed by mass spectrometry

  • Analyze interactome for enrichment of known NPC components

  • Compare results with established NPC interaction networks in S. pombe

• Functional Relationship Assessment:

  • Generate SPAC1002.01 deletion strains

  • Examine effects on nuclear transport using nuclear import/export assays

  • Compare phenotypes with those of known NPC component mutants

• Evolutionary Analysis:

  • Perform phylogenetic analysis comparing SPAC1002.01 with known NPC components

  • Identify conserved domains or motifs shared with NPC proteins

  • Evaluate evolutionary conservation patterns across yeast species

• Structural Biology Approaches:

  • If high-resolution structures exist for SPAC1002.01 or can be predicted

  • Compare structural features with known NPC components

  • Identify potential binding interfaces that might interact with the nuclear pore

These methodological approaches would help elucidate whether SPAC1002.01 functions in association with the nuclear pore complex, perhaps as a peripheral component or regulatory factor not previously identified in systematic studies of the S. pombe NPC .

How can SPAC1002.01 antibody be integrated with advanced imaging techniques?

Integrating SPAC1002.01 antibody with cutting-edge imaging methodologies enables sophisticated visualization of this protein in cellular contexts:

• Super-Resolution Microscopy Applications:

  • For Structured Illumination Microscopy (SIM): Use fluorescently-labeled secondary antibodies with SPAC1002.01 primary antibody

  • For STORM/PALM: Consider direct labeling of SPAC1002.01 antibody with photoactivatable fluorophores

  • Protocol modification: Reduce background through optimized blocking (5% BSA in PBS with 0.1% Triton X-100) and extended washing steps

• Live-Cell Imaging Approaches:

  • While direct use of antibodies is limited in live cells, correlative approaches can be developed:

  • Express fluorescently-tagged SPAC1002.01 for live imaging

  • Fix and perform immunostaining with SPAC1002.01 antibody

  • Align images to correlate dynamic behaviors with antibody-validated localization

• Multi-Color Co-Localization Strategy:

  • Combine SPAC1002.01 antibody with markers for cellular compartments

  • Use spectral unmixing to resolve signals from multiple fluorophores

  • Quantify co-localization using Pearson's or Mander's coefficients

  • Suggested markers: nuclear envelope (Nup proteins), chromatin (H2B), endoplasmic reticulum markers

• Volume Electron Microscopy Integration:

  • Implement immunogold labeling with SPAC1002.01 antibody

  • Process for serial block-face scanning electron microscopy

  • Reconstruct 3D ultrastructural context of SPAC1002.01 localization

• Expansion Microscopy Protocol:

  • After primary immunolabeling with SPAC1002.01 antibody

  • Embed in expandable hydrogel

  • Physically expand specimen to achieve super-resolution with standard confocal microscopy

These advanced imaging approaches should be preceded by thorough validation of antibody specificity in immunofluorescence applications, as this use extends beyond the manufacturer's validated applications (ELISA and Western blot) .

What are common causes of weak or absent signal when using SPAC1002.01 antibody?

When encountering weak or absent signals with SPAC1002.01 antibody, systematically investigate these potential methodological issues:

• Protein Expression Levels:

  • SPAC1002.01 may be expressed at low levels under standard growth conditions

  • Solution: Optimize growth conditions or consider concentration methods like immunoprecipitation before analysis

• Epitope Accessibility Issues:

  • The target epitope may be masked by protein folding or interactions

  • Solution: Test different sample preparation methods, including more stringent denaturation conditions or alternative detergents

• Antibody Activity Loss:

  • Repeated freeze-thaw cycles or improper storage may have compromised antibody function

  • Solution: Aliquot antibody upon receipt and store at recommended temperatures (-20°C or -80°C)

• Insufficient Antibody Concentration:

  • The standard dilution may be insufficient for detection

  • Solution: Perform a titration experiment testing more concentrated antibody solutions

• Inadequate Incubation Conditions:

  • Short incubation times or suboptimal temperatures may reduce binding efficiency

  • Solution: Extend primary antibody incubation (overnight at 4°C) and optimize temperature

• Detection System Sensitivity:

  • Standard ECL may be insufficient for low-abundance proteins

  • Solution: Use high-sensitivity detection reagents or consider signal amplification systems

• Transfer Efficiency Problems:

  • Proteins may not have transferred efficiently to the membrane

  • Solution: Verify transfer with reversible total protein stains like Ponceau S

• Sample Degradation:

  • Target protein may have degraded during sample preparation

  • Solution: Add fresh protease inhibitors and keep samples cold throughout processing

Maintaining a systematic troubleshooting log will help identify patterns and resolve issues with SPAC1002.01 antibody applications .

How can background signal be reduced when working with SPAC1002.01 antibody?

To methodically reduce background signal when working with SPAC1002.01 antibody, implement these evidence-based optimization strategies:

• Blocking Optimization:

  • Test alternative blocking agents: 5% BSA, 5% non-fat milk, commercial blocking buffers

  • Extend blocking time to 2 hours at room temperature or overnight at 4°C

  • Include 0.1-0.3% Tween-20 in blocking buffer to reduce non-specific binding

• Antibody Dilution Refinement:

  • Perform systematic dilution series to identify optimal concentration

  • Start with manufacturer's recommended dilution and test 2-fold serial dilutions

  • Balance specific signal retention with background reduction

• Washing Protocol Enhancement:

  • Increase washing frequency (5-6 washes of 5-10 minutes each)

  • Use larger volumes of wash buffer

  • Consider adding higher concentrations of detergent (0.1-0.5% Tween-20) in wash buffers

• Pre-absorption Strategy:

  • Pre-absorb antibody with S. pombe lysate from a SPAC1002.01 deletion strain

  • Incubate diluted antibody with membrane containing non-specific proteins

• Secondary Antibody Considerations:

  • Reduce secondary antibody concentration

  • Select highly cross-adsorbed secondary antibodies

  • Consider using secondary antibodies from alternative vendors

• Buffer Optimization:

  • Test different buffer systems (PBS vs. TBS)

  • Adjust salt concentration (150-500 mM NaCl) to increase stringency

  • Add 0.1-1% carrier proteins (BSA) to antibody dilution buffer

• Sample Preparation Refinement:

  • Implement additional clarification steps (higher speed centrifugation)

  • Consider pre-clearing samples with Protein A/G beads

  • Filter lysates through 0.45 μm filters to remove particulates

• Alternative Detection Methods:

  • For Western blots, consider fluorescent secondary antibodies instead of HRP-conjugated

  • For ELISA, test different substrate systems with varying sensitivities

These methodological refinements should be tested systematically, changing one variable at a time to identify the optimal conditions for reducing background while maintaining specific SPAC1002.01 signal .

What controls should be included when working with SPAC1002.01 antibody?

For rigorous scientific validation of SPAC1002.01 antibody experiments, incorporate these essential controls:

• Genetic Controls:

  • Positive Control: Wild-type S. pombe expressing normal levels of SPAC1002.01

  • Negative Control: SPAC1002.01 deletion strain (if available)

  • Expression Control: S. pombe strain overexpressing SPAC1002.01 (useful for confirming band identity)

• Antibody Controls:

  • Primary Antibody Omission: Samples processed identically but without SPAC1002.01 antibody

  • Isotype Control: Non-specific rabbit IgG at equivalent concentration

  • Pre-immune Serum Control: If available, compare with the specific antibody

  • Peptide Competition: Pre-incubation of antibody with immunizing antigen to block specific binding

• Technical Controls:

  • Loading Control: Blots should be probed for housekeeping proteins (e.g., actin, tubulin) to normalize loading

  • Molecular Weight Markers: To confirm expected size of detected protein

  • Transfer Efficiency Control: Reversible total protein stain (Ponceau S) to verify transfer

  • Secondary Antibody Only: To detect potential non-specific binding of secondary antibody

• Application-Specific Controls:

  • For ELISA: Standard curve using recombinant SPAC1002.01 protein

  • For Immunoprecipitation: Input sample alongside IP and control IP samples

  • For Immunofluorescence: Secondary antibody alone and peptide competition controls

• Sample Preparation Controls:

  • Protease Inhibitor Tests: Samples prepared with and without protease inhibitors

  • Denaturation Controls: Samples processed under different denaturation conditions

• Cross-Reactivity Assessment:

  • Testing antibody against lysates from other yeast species or related organisms

Systematic implementation of these controls ensures scientific rigor and facilitates troubleshooting if experimental issues arise .

How can researchers determine if SPAC1002.01 antibody's activity has diminished over time?

To methodically assess potential activity loss in SPAC1002.01 antibody over time, implement these quantitative and comparative approaches:

• Time-Course Comparison Testing:

  • Perform side-by-side Western blot using newly obtained SPAC1002.01 antibody alongside stored antibody

  • Standardize all conditions (sample, dilutions, exposure time)

  • Quantify and compare signal intensities using densitometry software

• Sensitivity Threshold Analysis:

  • Prepare serial dilutions of S. pombe lysate

  • Test with both new and stored antibody

  • Compare detection limits (the lowest concentration yielding visible signal)

  • Calculate fold-difference in sensitivity

• Quality Control Sample Repository:

  • Create aliquots of standardized positive control lysate upon first antibody use

  • Store these reference samples at -80°C

  • Test new experiments against these standards to detect sensitivity drift

• Titration Curve Shift Assessment:

  • Generate antibody dilution curves (e.g., 1:500, 1:1000, 1:2000, 1:5000)

  • Compare curve shapes between fresh and stored antibody

  • Shift in EC50 (dilution giving half-maximal signal) indicates activity loss

• Signal-to-Noise Ratio Calculation:

  • Calculate ratio of specific signal to background for both fresh and stored antibody

  • Declining ratio suggests deterioration in antibody quality

• Epitope Recognition Profile:

  • If multiple bands were initially detected, changes in band pattern may indicate epitope recognition alteration

  • Document band patterns with initial use as reference

• Storage Condition Verification:

  • Ensure antibody has been consistently stored at recommended temperatures (-20°C or -80°C)

  • Check for evidence of repeated freeze-thaw cycles which significantly impact antibody stability

• Functional Verification:

  • For applications beyond Western blot, test functional capacity in immunoprecipitation or other techniques

  • Compare efficiency metrics with baseline data

If significant activity loss is detected (>50% reduction in signal or detection limit), consider ordering fresh antibody, as reconditioning approaches are typically ineffective for severely degraded antibodies .

How might SPAC1002.01 relate to chromatin regulation mechanisms in S. pombe?

While direct evidence linking SPAC1002.01 to chromatin regulation is not explicitly presented in the search results, methodological approaches for investigating potential relationships can be developed based on known chromatin regulatory mechanisms in S. pombe:

• Comparative Analysis with Known Chromatin Regulators:

  • The search results mention several S. pombe proteins involved in chromatin regulation, including those affecting histone H4 K20 trimethylation, H4 K16 acetylation, and HDAC-related functions

  • Experimental approach: Compare phenotypes between SPAC1002.01 deletion and deletions of these known regulators

  • Implement epistasis analysis to determine if SPAC1002.01 functions in the same or parallel pathways

• Histone Modification Profiling:

  • Methodology: Generate SPAC1002.01 deletion strains and analyze global levels of key histone modifications

  • Focus on modifications mentioned in the context of other S. pombe chromatin proteins:

    • H4 K20 trimethylation

    • H4 K16 acetylation

    • Other acetylation and methylation marks on histones H3 and H4

  • Compare modification patterns with wild-type cells using quantitative mass spectrometry or modification-specific antibodies

• Chromatin Association Analysis:

  • Implement chromatin fractionation protocols to determine if SPAC1002.01 associates with chromatin

  • Perform ChIP-seq to map genomic binding sites if association is detected

  • Analyze binding patterns relative to heterochromatin domains, subtelomeric regions, and other regulatory elements

• HDAC Inhibitor Sensitivity Testing:

  • Test sensitivity of SPAC1002.01 deletion strains to Trichostatin A (TSA) and other HDAC inhibitors

  • Compare with sensitivity patterns of known chromatin regulators like Msc1

  • Analyze potential genetic interactions with HDAC components

• Gene Expression Analysis in Deletion Strains:

  • Perform RNA-seq or microarray analysis of SPAC1002.01 deletion strains

  • Look specifically at expression changes in subtelomeric genes, which have been associated with chromatin regulation in S. pombe

  • Compare expression profiles with those of known chromatin regulator deletions

These approaches would help establish whether SPAC1002.01 plays a role in chromatin regulation pathways similar to those described for other S. pombe proteins in the available literature .

How can SPAC1002.01 antibody be used for advanced protein interaction studies?

For investigating SPAC1002.01 protein interactions using sophisticated methodological approaches:

• Co-Immunoprecipitation with Quantitative Mass Spectrometry:

  • Perform immunoprecipitation using SPAC1002.01 antibody under various conditions:

    • Native conditions to preserve physiological interactions

    • Cross-linked conditions to capture transient interactions

    • Different cell cycle stages or stress conditions

  • Process samples for mass spectrometry using:

    • TMT or iTRAQ labeling for quantitative comparison

    • Label-free quantification with multiple replicates

    • SILAC approaches for higher confidence

  • Implement stringent statistical analysis to filter true interactors from background

• Proximity-Dependent Labeling Approaches:

  • Generate fusion proteins combining SPAC1002.01 with:

    • BioID/TurboID for proximity biotinylation

    • APEX2 for peroxidase-based proximity labeling

  • Use SPAC1002.01 antibody to validate expression and localization of fusion proteins

  • Compare proximity interactome with direct immunoprecipitation results

• Reciprocal Co-Immunoprecipitation Validation:

  • For identified interaction candidates:

    • Generate epitope-tagged versions

    • Perform reverse immunoprecipitation

    • Blot with SPAC1002.01 antibody to confirm interaction

  • Quantify co-precipitation efficiency under different conditions

• In situ Proximity Ligation Assay (PLA):

  • Use SPAC1002.01 antibody in combination with antibodies against candidate interactors

  • Optimize fixation and permeabilization for S. pombe cells

  • Quantify PLA signals to measure interaction frequency in different cellular compartments

• Protein Fragment Complementation:

  • For specific candidate interactions:

    • Create split-reporter fusion constructs (split-GFP, split-luciferase)

    • Validate expression using SPAC1002.01 antibody

    • Measure reconstituted reporter signal as indicator of interaction

• Structural Validation:

  • For high-confidence interactions:

    • Express and purify recombinant proteins

    • Perform in vitro binding assays

    • Consider structural studies (X-ray crystallography, cryo-EM)

These advanced methodologies extend beyond the basic validated applications of the SPAC1002.01 antibody but would provide comprehensive insights into the protein's functional interaction network .

What insights can be gained from comparing SPAC1002.01 to related proteins in other model organisms?

Comparative analysis of SPAC1002.01 with homologs in other organisms requires sophisticated methodological approaches combining bioinformatics and experimental validation:

• Evolutionary Profile Analysis:

  • Implement sensitive homology detection methods (PSI-BLAST, HHpred) to identify distant homologs

  • Construct phylogenetic trees to trace evolutionary relationships

  • Identify conserved domains and motifs across species

  • Calculate selection pressure (dN/dS ratios) on different protein regions to identify functionally critical segments

• Cross-Species Complementation Studies:

  • Clone SPAC1002.01 homologs from other organisms into S. pombe expression vectors

  • Express in SPAC1002.01 deletion strains

  • Use SPAC1002.01 antibody to verify absence of native protein

  • Assess complementation of phenotypes to determine functional conservation

• Domain Function Conservation Assessment:

  • Identify domains through tools like InterPro, SMART, or Pfam

  • Compare with domain architectures of homologs in other organisms

  • Create chimeric proteins swapping domains between S. pombe SPAC1002.01 and homologs

  • Test functionality using phenotypic assays and antibody validation

• Interactome Conservation Analysis:

  • Compare protein interaction networks of SPAC1002.01 with those of homologs

  • Implement network alignment algorithms to identify conserved interaction modules

  • Test whether interaction partners have homologs that interact in other organisms

• Structural Comparison Methodology:

  • Generate structural models using AlphaFold or similar prediction tools

  • Compare predicted structures across homologs

  • Identify structurally conserved regions that may indicate functional sites

  • Design experiments to test functional predictions using the antibody for validation

• Regulatory Mechanism Comparison:

  • Compare expression patterns, post-translational modifications, and localization

  • Determine if regulatory mechanisms are conserved across species

  • Use the antibody to track S. pombe SPAC1002.01 under conditions mimicking those studied in other organisms

This comparative approach would provide insights into evolutionary conservation and divergence of SPAC1002.01 function, potentially revealing fundamental biological roles conserved across eukaryotic evolution .